Effects of intermittent intraperitoneal infusion of salmon calcitonin on food intake and adiposity in obese rats
Open Access
- 1 November 2007
- journal article
- Published by American Physiological Society in American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
- Vol. 293 (5), R1798-R1808
- https://doi.org/10.1152/ajpregu.00386.2007
Abstract
Chronic administration of anorexigenic substances to experimental animals by injections or continuous infusion typically produces no effect or a transient reduction in daily food intake and body weight. Our aim was to identify an intermittent dosing strategy for intraperitoneal infusion of salmon calcitonin (sCT), a homolog of amylin that produces a sustained 25–35% reduction in daily food intake and adiposity in diet-induced obese rats. Rats (649 ± 10 g body wt, 27 ± 1% body fat), with intraperitoneal catheters tethered to infusion swivels, had free access to a 45% fat diet. Food intake, body weight, and adiposity during the 7-wk test period were relatively stable in the vehicle-treated rats ( n = 16). None of 10 sCT dosing regimens administered in succession to a second group of rats ( n = 18) produced a sustained 25–35% reduction in daily food intake for >5 days, although body weight and adiposity were reduced by 9% (587 ± 12 vs. 651 ± 14 g) and 22% (20.6 ± 1.2 vs. 26.5 ± 1.1%), respectively, across the 7-wk period. The declining inhibitory effect of sCT on daily food intake with the 6-h interinfusion interval appeared to be due in part to an increase in food intake between infusions. The declining inhibitory effect of sCT on daily food intake with the 2- to 3-h interinfusion interval suggested possible receptor downregulation and tolerance to frequent sCT administration; however, food intake increased dramatically when sCT was discontinued for 1 day after apparent loss of treatment efficacy. Together, these results demonstrate the activation of a potent homeostatic response to increase food intake when sCT reduces food intake and energy reserves in diet-induced obese rats.Keywords
This publication has 40 references indexed in Scilit:
- Intermittent intraperitoneal infusion of peptide YY(3-36) reduces daily food intake and adiposity in obese ratsAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2007
- Antiobesity action of peripheral exenatide (exendin-4) in rodents: effects on food intake, body weight, metabolic status and side-effect measuresInternational Journal of Obesity, 2006
- Diabesity: A Polygenic Model of Dietary-Induced Obesity from Ad Libitum Overfeeding of Sprague–Dawley Rats and Its Modulation by Moderate and Marked Dietary RestrictionToxicologic Pathology, 2005
- Biological importance of the peptides of the calcitonin family as revealed by disruption and transfer of corresponding genesPeptides, 2004
- New Data on Appetite-Suppressing Peptide Challenge CriticsScience, 2004
- Effects of PYY[3–36] in rodent models of diabetes and obesityInternational Journal of Obesity, 2004
- Causes and Problems of Nonresponse or Poor Response to DrugsDrugs, 1996
- An investigation of tolerance to the actions of leptogenic and anorexigenic drugs in miceLife Sciences, 1987
- Rapid development of tolerance to the behavioural actions of cholecystokininNature, 1983
- Ability of calcitonins to alter food and water consumption in the ratPeptides, 1982